Načítá se...
Rationally Designed Anti-CRISPR Nucleic Acid Inhibitors of CRISPR-Cas9
Clustered regularly interspaced short palindromic repeat (CRISPR) RNAs and their associated effector (Cas) enzymes are being developed into promising therapeutics to treat disease. However, CRISPR-Cas enzymes might produce unwanted gene editing or dangerous side effects. Drug-like molecules that can...
Uloženo v:
| Vydáno v: | Nucleic Acid Ther |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Mary Ann Liebert, Inc., publishers
2019
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6555185/ https://ncbi.nlm.nih.gov/pubmed/30990769 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1089/nat.2018.0758 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|